Congress reimports drugs a freedom vs policy debate
An American perspective criticizes congressional approval of reimporting U S manufactured prescription drugs from Canada and elsewhere. The piece argues freedom to buy abroad conflicts with patents and FDA rules, noting price controls in Canada and the risk to life-saving drug development.
MENTIONED IN THIS ARTICLE
Eds
US House
Senate
Canada
U.S. House
Congress
U.S
Congressional
United States
Food and Drug Administration
FDA
Also Mentioned on This Page
By Sheldon Richman
Manitoba
Gov.mb.ca
Winnipeg
Us Health
Iness
Mar
Prairie Gardener
Roblin Plant
Russell Plant
Russell Avenue
Roblin
Russell
Grant Ferster
Mitchell's
Key
B.C. Apricots
G.L.H
Cates Service Club
Organi Commercial Travel
Bicycle and Rider Classic Car
the Chamber of Commerce One
Questicg
Chamber Ofi
Windsor
Main Street